Requip tablets 0.25mg, manufactured by GlaxoSmithKline, contain Ropinirole Hydrochloride. This medication, with YJ code 1169013F1027 and a standard of 0.25 mg per tablet, is a dopamine agonist used to treat Parkinson’s disease and moderate-to-severe restless legs syndrome.
Requip tablets 0.25mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
